首页> 外文期刊>Japanese journal of clinical oncology. >Two novel gross deletions of TSC2 in Malaysian patients with tuberous sclerosis complex and TSC2/PKD1 contiguous deletion syndrome.
【24h】

Two novel gross deletions of TSC2 in Malaysian patients with tuberous sclerosis complex and TSC2/PKD1 contiguous deletion syndrome.

机译:马来西亚患有结节性硬化症和TSC2 / PKD1连续缺失综合征的患者中有两个新颖的TSC2总体缺失。

获取原文
获取原文并翻译 | 示例
           

摘要

Tuberous sclerosis complex is an autosomal dominant neurocutaneous disorder affecting multiple organs. Tuberous sclerosis complex is caused by mutation in either one of the two disease-causing genes, TSC1 or TSC2, encoding for hamartin and tuberin, respectively. TSC2/PKD1 contiguous gene deletion syndrome is a very rare condition due to deletion involving both TSC2 and PKD1 genes. Tuberous sclerosis complex cannot be easily diagnosed since there is no pathognomonic feature, although there are consensus diagnostic criteria for that. Mutation analysis is useful and plays important roles. We report here two novel gross deletions of TSC2 gene in Malay patients with tuberous sclerosis complex and TSC2/PKD1 contiguous gene deletion syndrome, respectively.
机译:结节性硬化症是影响多个器官的常染色体显性遗传神经皮肤疾病。结节性硬化症复合物是由两个致病基因之一TSC1或TSC2中的一个突变引起的,分别编码ha豆素和块茎蛋白。由于涉及TSC2和PKD1基因的缺失,TSC2 / PKD1连续基因缺失综合征是一种非常罕见的疾病。尽管没有共识性的诊断标准,但由于尚无病理特征,因此结核结节性硬化复合物不易诊断。突变分析是有用的,并且起着重要的作用。我们在这里报告马来结节性硬化症和TSC2 / PKD1连续基因缺失综合征的马来患者中的TSC2基因的两个新颖的总体缺失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号